Key Market Indicators
Sales of Chilean antacid medicine are projected to reach $17 million by 2026. In 2021, the country was fourth on the list with $16.4 million in sales, behind Italy, Germany and Chile, respectively. Since 2005, the antacid market in Chile has been declining at a rate of 0.3% each year.
